SCOPUS 정보 검색 플랫폼

Practitioner

Volumn 256, Issue 1748, 2012, Pages 13-16

Early diagnosis improves survival in kidney cancer

(2) Lewis, Gareth a Maxwell, Alexander P b

a Nephrology ^* (United Kingdom)

b BELFAST CITY HOSPITAL (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CONFERENCE PAPER; EARLY DIAGNOSIS; ENVIRONMENTAL EXPOSURE; GENETIC PREDISPOSITION; HUMAN; KIDNEY TUMOR; LIFESTYLE; METHODOLOGY; ORGANIZATION AND MANAGEMENT; PATHOLOGY; PRIMARY HEALTH CARE; RISK FACTOR; TIME;

EARLY DETECTION OF CANCER; ENVIRONMENTAL EXPOSURE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; KIDNEY NEOPLASMS; LIFE STYLE; PRIMARY HEALTH CARE; RISK FACTORS; TIME FACTORS;

EID: 84857860642 PISSN: 00326518 EISSN: None Source Type: Journal
DOI: None Document Type: Conference Paper

Times cited : (14)

References (13)

1
- 67650760958
- Epidemiology of kidney cancer
- Epub 2008 Nov. 4
- Pascual D, Borque A. Epidemiology of kidney cancer. Adv Urol 2008;782381. Epub 2008 Nov. 4
- (2008) Adv Urol , pp. 782381
- Pascual, D.¹ Borque, A.²

2
- 62849128369
- Renal cell carcinoma
- Rini BI, Campbell SC, Escudier B. Renal cell carcinoma. Lancet 2009;373:1119-1132
- (2009) Lancet , vol.373 , pp. 1119-1132
- Rini, B.I.¹ Campbell, S.C.² Escudier, B.³

3
- 0035964602
- Obesity and renal cell cancer - A quantitative review
- DOI 10.1038/sj.bjc.6692040
- Bergström A, Hsieh CC, Lindblad P et al. Obesity and renal cell cancer - a quantitative review. Br J Cancer 2001;85(7):984-990 (Pubitemid 33016001)
- (2001) British Journal of Cancer , vol.85 , Issue.7 , pp. 984-990
- Bergstrom, A.¹ Hsieh, C.-C.² Lindblad, P.³ Lu, C.-M.⁴ Cook, N.R.⁵ Wolk, A.⁶

4
- 77952248366
- Epidemiology and risk factors for kidney cancer
- Wong-Ho C, Dong LM, Devesa SS. Epidemiology and risk factors for kidney cancer. Nat Rev Urol 2010;7(5):245-257
- (2010) Nat Rev Urol , vol.7 , Issue.5 , pp. 245-257
- Wong-Ho, C.¹ Dong, L.M.² Devesa, S.S.³

5
- 77954978435
- Advances in the genetics of familial renal cancer
- Morrison PJ, Donnelly DE, Atkinson AB, Maxwell AP. Advances in the genetics of familial renal cancer. Oncologist 2010;15:532-538
- (2010) Oncologist , vol.15 , pp. 532-538
- Morrison, P.J.¹ Donnelly, D.E.² Atkinson, A.B.³ Maxwell, A.P.⁴

6
- 30044444423
- National Institute for Health and Clinical Excellence. CG27, NICE. London
- National Institute for Health and Clinical Excellence. CG27. Referral guidelines for suspected cancer. NICE. London. 2005
- (2005) Referral Guidelines for Suspected Cancer

7
- 3242750568
- The Mayo-Clinic experience with surgical management complications and outcome for patients with renal cell carcinoma and venous tumour thrombus
- DOI 10.1111/j.1464-410X.2004.04897.x
- Blute ML, Leibovich BC, Lohse CM et al. The Mayo clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumour thrombosis. BJU Int 2004;94:33-41 (Pubitemid 38980305)
- (2004) BJU International , vol.94 , Issue.1 , pp. 33-41
- Blute, M.L.¹ Leibovich, B.C.² Lohse, C.M.³ Cheville, J.C.⁴ Zincke, H.⁵

8
- 79960977418
- The outcome of patients treated with sunitinib prior to planned nephrectomy in metastatic clear cell renal cancer
- Powles T, Blank C, Chowdhury S et al. The outcome of patients treated with sunitinib prior to planned nephrectomy in metastatic clear cell renal cancer. Eur Urol 2011;60:448-454
- (2011) Eur Urol , vol.60 , pp. 448-454
- Powles, T.¹ Blank, C.² Chowdhury, S.³

9
- 79958089467
- Recent developments in kidney cancer
- Leveridge MJ, Jewett MAS. Recent developments in kidney cancer. Can Urol Assoc J 2011;5(3):195-203
- (2011) Can Urol Assoc J , vol.5 , Issue.3 , pp. 195-203
- Leveridge, M.J.¹ Jewett, M.A.S.²

10
- 77956638944
- National Institute for Health and Clinical Excellence. TA169, NICE. London
- National Institute for Health and Clinical Excellence. TA169. Sunitinib for the first-line treatment of advanced and/or metastatic renal cell carcinoma. NICE. London. 2009
- (2009) Sunitinib for the First-line Treatment of Advanced And/or Metastatic Renal Cell Carcinoma

11
- 33744954585
- Sunitinib in patients with metastatic renal cell carcinoma
- DOI 10.1001/jama.295.21.2516
- Motzer RJ, Rini BI, Bukowski RM et al. Sunitinib in patients with metastatic renal cell carcinoma. JAMA 2006;295:2516-2524 (Pubitemid 43854967)
- (2006) Journal of the American Medical Association , vol.295 , Issue.21 , pp. 2516-2524
- Motzer, R.J.¹ Rini, B.I.² Bukowski, R.M.³ Curti, B.D.⁴ George, D.J.⁵ Hudes, G.R.⁶ Redman, B.G.⁷ Margolin, K.A.⁸ Merchan, J.R.⁹ Wilding, G.¹⁰ Ginsberg, M.S.¹¹ Bacik, J.¹² Kim, S.T.¹³ Baum, C.M.¹⁴ Michaelson, M.D.¹⁵

12
- 77955602985
- Which patients with renal cancer may benefit from sunitinib therapy?
- Ferguson T, Gore M. Which patients with renal cancer may benefit from sunitinib therapy? Ther Adv Med Oncol 2010;2(2):69-74
- (2010) Ther Adv Med Oncol , vol.2 , Issue.2 , pp. 69-74
- Ferguson, T.¹ Gore, M.²

13
- 41149108218
- Toxicities associated with the administration of sorafenib, sunitinib and temsirolimus and their management in patients with metastatic renal cell carcinoma
- Bhojani N, Jeldres C, Patard JJ et al. Toxicities associated with the administration of sorafenib, sunitinib and temsirolimus and their management in patients with metastatic renal cell carcinoma. Eur Urol 2008;53:917-930
- (2008) Eur Urol , vol.53 , pp. 917-930
- Bhojani, N.¹ Jeldres, C.² Patard, J.J.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.